fda approval for tirzepatide Grants a New Indication Obesity Management FDA says the tirzepatide weight-loss

Moreover, OR2AT4 and OR2J3 are functionally expressed in human bronchial epithelial cells

Serious side effects are rare but can include pancreatitis or gallbladder problems

By improving how your body processes glucose and uses insulin, inositol supplementation targets one of the root causes of metabolic syndrome, a condition that affects millions of women and significantly increases heart disease risk

doi: 10.1111/1440-1681.13206 58 RonnJ.JensenE

That's not a finding suggesting GLP-1s should be avoided - it's a finding suggesting that musculoskeletal support, including resistance training, isn't optional for women on these medications